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Edited by Maurice MontalAbstract Protein ectodomain shedding is the proteolytic release
of the extracellular domain of membrane-bound proteins. Neuro-
trophin receptor p75NTR is known to be aﬀected by shedding.
The present work provides evidence, in rat brain synaptosomes,
that p75NTR is present in detergent-resistant membranes
(DRM), also known as lipid rafts, only in its full-length form.
Disrupting the integrity of lipid rafts causes solubilization of
p75NTR after detergent treatment and enhancement of the shed-
ding. Analyses of the enzymes described as being responsible for
p75NTR shedding, i.e. tumor necrosis factor a convertase
(TACE) and presenilin-1 (PS1), revealed that TACE is absent
in DRM, while variable proportions of the C-terminal and N-ter-
minal fragments of PS1 are found. In summary, our results point
to a role of lipid rafts in the modulation of the shedding of the
p75NTR receptor.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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The p75 neurotrophin receptor (p75NTR) is a multifunctional
Type I membrane protein with many faces. p75NTR can pro-
mote neurotrophin-induced neuronal survival and diﬀerentia-
tion by regulating the speciﬁcity and aﬃnity of the Trk
receptors [1], but it can also, on the contrary, act as a pro-
apoptotic receptor under certain conditions [2]. While the
Trk receptors are responsible for most of the survival and
growth properties of the neurotrophins, p75NTR is a Trk co-
receptor that can, ﬁrst, enhance or suppress neurotrophin-
mediated Trk receptor activity. Second, p75NTR autonomously
activates signaling cascades that result in the induction of
apoptosis or in the promotion of survival [3]. Diﬀerent neuro-
trophins show binding speciﬁcity for particular receptors:
nerve growth factor (NGF) binds preferentially to tyrosine
receptor kinase A (TrkA); brain-derived neurotrophic factor
(BDNF) and neurotrophin 4 (NT4) to TrkB, and NT3 to TrkC
[4]. On the contrary, the p75 receptor can bind to each neuro-
trophin with the same aﬃnity [5] and can increase the aﬃnity
of TrkA for NGF and enhance its speciﬁcity for cognate neu-*Corresponding author. Fax: +34 93 581 1573.
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proteins, including pathogens, participating in their internali-
zation and transport [7]. The p75NTR is included in the TNFR
superfamily [8], whose members do not have intrinsic enzy-
matic activity, and signaling occurs through association with
cytoplasmic adaptor proteins. The p75NTR intracellular do-
main (ICD) contains several regions likely to mediate interac-
tions with downstream signaling elements [3]. These proteins
have been largely isolated using yeast two-hybrid screens and
include NRAGE, NADE, TRAF proteins, SC-1, and NRIF
1 and 2 [9–12]. In addition to the complex array of interactions
of p75NTR, the actions of this receptor can be regulated by
means of controlled proteolysis, in a process called ‘‘ectodo-
main shedding’’ [13]. This process, which occurs in many mem-
brane receptors, is performed in most of the cases by ADAM
(a disintegrin and metalloproteinase), a family of transmem-
brane zinc-dependent metalloproteinases [14], resulting in
detachment of their extracellular region (ectodomain). Shed-
ding can release cytokines, growth factors or other mediators
from their membrane-bound precursors or, conversely,
down-regulate receptors and other proteins from the cell sur-
face [15]. In the case of p75NTR, evidence for a critical role
of ADAM17 (also called tumor necrosis factor a convertase
or TACE) in its ectodomain shedding has been described
[16]. The action of TACE in the extracellular domain of
p75NTR is a pre-requisite for a subsequent cleavage in an intra-
membrane site, exerted by the c-secretase complex [17]. This
type of sequential proteolytic processing of shedded proteins
has been observed in several reports, and c-secretase is known
to be responsible for the intramembranous cleavage of other
Type I transmembrane proteins, such as Notch, CD44, and
E-cadherin [18]. This proteolytic processing of the p75NTR gen-
erates C-terminal fragments with signaling capability, activat-
ing NF-jB in concert with the TNF receptor associated factor
6 (TRAF6) [19]. Activation of c-secretase requires the forma-
tion of a stable, high-molecular-weight multiprotein complex,
which includes an endoproteolyzed and fragmented form of
presenilin, nicastrin (NCT), APH-1, and PEN-2 [20]. The
association of active c-secretase with lipid rafts, membrane
microdomains that are enriched in cholesterol and glyco-
sphingolipids [21, for review], has recently been described
[22]. This association of c-secretase with lipid rafts appears
to be crucial for the formation of the amyloid-b (Ab) peptide
in Alzheimer’s disease (AD), since the amyloidogenic cleavage
of amyloid precursor protein (APP) by the b- and c-secretases
appears to occur preferentially in cholesterol-rich lipid rafts
[23]. Similarly, the conversion of cellular prion protein (PrPC)
into the infectious PrPSc form is also likely to occur in these
membrane domains [24]. In fact, the cholesterol- and lipidblished by Elsevier B.V. All rights reserved.
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common feature in some proteins, such as CD30, a lymphoid
activation marker [25], or the interleukin-6 receptor [26], both
substrates of TACE.
In light of that described above, the aim of the present study
is to examine the inﬂuence of cholesterol-rich domains in the
shedding of p75NTR, in terms of spatial segregation at the
membrane level between p75NTR and its proteolytic system
(i.e., TACE and c-secretase). For this purpose, we used iso-
lated synaptosomal-enriched fraction from rat brain, a well
established model routinely used in our laboratory. Moreover,
the fact that c-secretase complex has been related to synaptic
alterations and events points to synaptosomes as a good sys-
tem to study c-secretase substrates as p75NTR. Our results in
rat brain nerve endings presented here indicate that cholesterol
is responsible for the maintaining of a p75NTR pool segregated
from its a-secretase (TACE). Thus, we propose that p75NTR
could become proteolyzed when it is located outside lipid rafts
due to its accessibility by TACE, while lipid rafts would pre-
vent a-secretase shedding of p75NTR by excluding TACE.2. Materials and methods
2.1. Antibodies
Polyclonal antibody against the cytoplasmic domain of the human
p75NTR came from Promega Corp. (Madison, WI, USA). Antibody
against the stalk domain (extracellular) of p75NTR (corresponding to
residues 188–203 of human p75NTR, EEIPGRWIPRSTPPEGSDSTA)
was also raised in rabbit and was purchased from Alomone Labs Ltd.
(Jerusalem, Israel). Monoclonal antibody (clone H68.4) against the
transferrin receptor was from Zymed Laboratories (San Francisco,
CA, USA). Monoclonal antibody (clone OX7) against Thy-1 was a gift
from Dr. G. Schiavo (Cancer Research UK; London, UK). Polyclonal
antibody against TNF-a converting enzyme (TACE) used in Western
blot was purchased by Calbiochem and rose using a synthetic peptide
corresponding to aminoacids 807–823 of human TACE. A polyclonal
antibody from Santa Cruz Biotech and raisen against the extracellular
domain of TACE was used in immunoﬂuorescence detections. This se-
quence diﬀers from those of rat by one aminoacid. Polyclonal antibody
against the C-terminal fragment of presenilin-1 (residues 303–316) was
from Oncogene, and antibody against the N-terminal portion of prese-
nilin-1 (residues 1–65) was from Calbiochem. Polyclonal antibody
against the aminoacid sequence 88–102 of Rat NRH2 was from Ab-
cam (Cambridge, UK). Every primary antibody was used at a 1:1000
dilution in the Western blot incubations.
2.2. Preparation of synaptosomes from rat brain
Crude synaptosomal fraction (P2) was prepared from Sprague–
Dawley, 4-to-6-week-old rat brains, as described previously [27], with
slight modiﬁcations. The whole brain was homogenized in 40 vol.
(w/v) of phosphate buﬀer (pH 7.4) supplemented with 0.32 M sucrose.
Homogenization was performed with 12 strokes (900 rev/min) of a
Potter homogenizer with a Teﬂon pestle (0.1 ± 0.15 mm clearance).
The homogenate was centrifuged at 1000 · g for 5 min at 4 C. The
resulting supernatant was centrifuged at 12000 · g for 20 min. The
crude synaptosomal pellet obtained from one brain was gently resus-
pended in 10 ml of sodium buﬀer containing 140 mM NaCl, 5 mM
KCl, 5 mM NaHCO3, 1 mM MgCl2, 1.2 mM Na2HPO4, 20 mM
HEPES/NaOH and 10 mM glucose, and the pH was adjusted to 7.4.
Protein concentration was determined according to the BCA protocol
(Pierce; USA).
2.3. Isolation of detergent-resistant membranes
Synaptosomal aliquots (3 mg total protein) were solubilized with
2 ml of cold sodium buﬀer containing 1% Lubrol WX (30 min at4 C), 1% Triton X-100 (30 min at 4 C) or 1% Brij 98 (30 min at
37 C) by end-over-end mixing. Thereafter, the extracts were adjusted
to 41% sucrose, and overlaid with 8 ml of 35% sucrose in sodium buﬀer
and 2.5 ml of 16% sucrose in sodium buﬀer, inside an ultracentrifuga-
tion tube. The detergent-resistant membranes (DRM) were isolated by
ultracentrifugation at 35000 rpm, for 18 h, 4 C, using a SW41 rotor
(Beckman Instruments Inc.). Then the gradient was harvested in 12
fractions of 1 ml. When indicated, synaptosomes were treated with
methyl-b-cyclodextrin (50 mM) for 15 min, prior to the detergent sol-
ubilization, in order to remove cholesterol from the plasma membrane.
DRM is used as a synonym of lipid rafts, and both terms are used
indiﬀerently throughout the article.
2.4. Electrophoresis and Western blot
Samples of each fraction from the sucrose gradient were analyzed by
SDS–PAGE followed by Western blot. The separated proteins were
transferred to a Protran nitrocellulose membrane (Schleicher and
Schuell; Dassel, Germany), using a Mini TransBlot Cell 3 (Bio-Rad;
CA, USA) at 100 V for 1 h. The blotting buﬀer used contained
25 mM Tris, 200 mM glycine and 10% (v/v) methanol. The membrane
ﬁlters were blocked for 1 h with Tris-buﬀered saline, supplemented
with 0.1% Tween 20 and 5% (w/v) defatted powdered milk. Following
this, the membranes were incubated overnight with the corresponding
antibody diluted in blocking buﬀer. Next, the membrane ﬁlters were
incubated for 1 h with a secondary antibody conjugated with horserad-
ish peroxidase diluted in blocking buﬀer. Several washes with Tris-buf-
fered saline/0.1% Tween 20 were performed between each step. The
Western blots were developed using ECL detection reagents from
Amersham Pharmacia Biotech (Little Chalfont, UK) and visualized
using a GeneGnome HR chemiluminescence detection system coupled
to a CCD camera (Syngene; Cambridge, UK). When required, quanti-
ﬁcation of the bands was performed with the GeneTools program
(Syngene; UK), which is able to detect saturated signals. Only non-sat-
urated signals were used for quantiﬁcation purposes.
2.5. Immunocytochemistry
The synaptosomes on coverslips, previously treated with polylysine
(Sigma), were ﬁxed with 4% paraformaldehyde for 20 min and washed
three times with phosphate-buﬀered saline (PBS). The ﬁxed synapto-
somes were ﬁrst incubated for 1 h at room temperature with the block-
ing solution (PBS, Triton X-100 0.01%, gelatine 0.2% and fetal bovine
serum, FBS, 10%) and then with the primary antibodies in the same
buﬀer (but only with 1% of FBS) overnight at 4 C. The primary anti-
bodies were used at the following dilutions: anti-Thy-1, 1:300, anti-
TACE (Santa Cruz Biotech.), 1:50. After incubation with primary
antibodies, synaptosomes were washed three times with PBS at room
temperature for 10 min each wash. Alexa-546-conjugated anti-rabbit
immunoglobulins or Alexa-488-conjugated anti-mouse immunoglobu-
lin secondary antibodies (Invitrogen) were used at a 1:400 dilution for
1 h at room temperature in the same buﬀer as the primary antibody.
Synaptosomes were washed three times with PBS at room temperature
for 10 min and then the coverslips were mounted with ﬂuorescence
mounting medium (Dako, Denmark). Slides were observed using a
Leica TCS SP2 confocal microscope.3. Results
3.1. p75NTR present in detergent-resistant membranes from nerve
endings does not show proteolytic processing
Lipid microdomains can be distinguished and isolated by
their diﬀerential solubility in detergents. Since there is growing
evidence for the existence of heterogeneity among lipid rafts,
which diﬀer in their speciﬁc lipid and protein composition,
physical properties, and biological functions [28], we address
the analysis of p75NTR in lipid rafts using the detergents Triton
X-100, Lubrol WX or Brij 98, alternatively. Twelve fractions
(1 mL each) from the discontinuous sucrose gradients after
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Fig. 1. Presence of p75NTR in DRM extracted alternatively with
diﬀerent detergents. Synaptosomes were solubilized with 1% Triton X-
100 for 30 min at 4 C (A), with 1% Lubrol WX for 30 min at 4 C (B)
or with 1% Brij 98 for 30 min at 37 C (C). Subsequently, each treated
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Brij 98, were collected and marker proteins were analyzed by
means of Western blot, in order to assess the correct lipid raft
separation. The glycosylphosphatidylinositol (GPI)-anchored
protein Thy-1 is a lipid raft marker, which appears only in
the upper fractions (Fractions 1–5, which correspond to
DRM) of the gradient obtained after Triton X-100 solubiliza-
tion (Fig. 1A), as well as in the gradients obtained after Lubrol
WX solubilization (Fig. 1B) or with Brij 98 (Fig. 1C). Solubi-
lization of synaptosomes with 1% Triton X-100 in the condi-
tions used in the present work has been described as
extracting virtually all of the cholesterol content in the DRM
fractions, evidence of a proper isolation of cholesterol-depen-
dent microdomains [27]. We used the transferrin receptor
(TfR) as marker of soluble membranes, an integral membrane
protein assumed to reside only in soluble membranes. In the
cases of Triton X-100 and of Brij 98 treatment, TfR is found
exclusively in the lower fractions of the gradients (Fractions
10–12, corresponding to soluble membranes), a result that
indicates a good separation of DRM from the bulk membrane
under the described conditions (Fig. 1A and C). In the case of
Lubrol WX, TfR is found in both DRM and soluble mem-
branes, a result that indicates an ineﬀective solubilization of
the bulk membrane (Fig. 1B). Afterwards, immunoblotting
analyses of the samples obtained alternatively with the two
detergents using an antibody against the entire intracellular
domain of p75NTR were performed. The results obtained using
each detergent were very similar, with p75NTR being present in
the DRM only in its full-length form, whereas processed forms
of 32 kDa and 40 kDa, approximately, in addition to the full-
length form, were detected in the solubilized membranes
(Fig. 1A–C). The two low-molecular-weight bands present in
the soluble membranes from each detergent treatment are
likely to correspond to the same polypeptide, in accordance
with their electrophoretic mobility (Fig. 2A). Since the cross-
reactivity of p75NTR-ICD antibodies with NRH2 (neurotro-
phin receptor homolog 2) has been described [29], we tested
this possibility by means of Western blot with anti-NRH2
(Fig. 2B). Although the molecular weight of NRH2 is
25 kDa, the results show that, in addition to the expected
band, another band of 40 kDa appears, both exclusively in sol-
uble membranes. Thus, the 40 kDa band observed with the p75
antibody is likely to represent a NRH2 moiety that cross-re-
acts with the anti-p75ICD antiserum. Analysis of gradients
from Triton X-100 using an antibody that recognizes the extra-
cellular stalk domain of p75NTR (residues 188–203 of human
p75NTR) corroborates that this domain is not present in any
other form than in the full-length protein present in both
DRM and soluble membranes (Fig. 2C).
sample was fractionated in a discontinuous sucrose gradient, as
detailed in Section 2. Equal volumes of the recovered fractions were
separated by SDS–PAGE and transferred to nitrocellulose for immu-
noblotting analysis by using antibodies against the indicated proteins.
Thy-1 (25 kDa) is used as a marker of lipid rafts, while the transferrin
receptor (TfR; 100 kDa) represents a marker of soluble membranes.
DRM are found in Fractions 1–4 and correspond to the top of the
ultracentrifuge tube, while Fractions 10–12 correspond to the soluble
membranes (SM). The full-length form of p75NTR (75 kDa) is
indicated on the right as FL. Additional bands appearing in soluble
fractions are indicated on the right with arrows (40 kDa, 32 kDa). This
analysis was repeated in three independent experiments with similar
results. Representative results are shown.3.2. Cholesterol depletion results in increased shedding
of p75NTR
In order to test the inﬂuence of cholesterol in the degree of
p75NTR shedding, as well as the cholesterol-dependence of
the raft association of p75NTR, synaptosomes were incubated
with the cholesterol-extracting drug methyl-b-cyclodextrin
(mbCD), at 50 mM for 15 min. Afterwards, separations of
the DRM fractions extracted with Triton X-100 (Fig. 3A) or
with Lubrol WX (Fig. 3B) were performed as described in Sec-
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Fig. 2. A cleavage site of p75NTR is localized between the stalk and the transmembrane domain. (A) Fraction 2, as a DRM fraction, and Fraction 12,
as a SM fraction, from each detergent solubilization (T, Triton X-100; L, Lubrol WX; B, Brij 98), were run in parallel in a SDS–PAGE and
subsequently blotted. p75NTR polypeptides were detected using an antibody against the entire intracellular domain (ICD). The same three bands were
detected in the SM fractions, corresponding to the full-length p75NTR (FL) and to two additional bands (40 kDa and 32 kDa). Molecular-weight
markers are shown on the left. (B) The 40 kDa band detected with the p75NTR-ICD antibody is likely to correspond to NRH2. The same fractions
corresponding to DRM (D) and to SM (S) were run in parallel and immunoblotted with anti-p75NTR-ICD (left) or with anti-NRH2 (right). The
NRH2 antibody yielded, only in the SM fraction, a 25 kDa band (marked on the right with an arrow), according to the predicted molecular weight of
NRH2, and two additional bands of 36 and 40 kDa, respectively. The 40 kDa bands which appeared with both antibodies are marked with a star,
and are likely to be the same, since cross-reactivity of this p75NTR-ICD antibody with NRH2 has been described [29]. The 32 kDa band (marked with
an arrowhead) is speciﬁc and, thus, corresponds to a p75NTR-ICD moiety. (C) A gradient from Triton X-100 solubilization was analyzed by Western
blot using an antibody against the stalk domain of p75NTR. Only the full-length (FL) form was recognized in each fraction. Molecular-weight
markers are shown on the left. All of these analyses were repeated in two (B) or three (A and C) independent experiments with similar results.
Representative results are shown.
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ubilization of p75NTR after every detergent treatment, thus dis-
appearing from DRM fractions due to removal of cholesterol,
and thus demonstrating the cholesterol-dependence of the lipid
raft association of p75NTR. The disappearance of p75NTR from
DRM correlates with the enhancement of the signal due to the
shedding fragment (32 kDa), especially in the Lubrol WX sol-
ubilization (Fig. 3B). The changes in the processed form of
p75NTR were quantiﬁed by means of the GeneTools program
from non-saturated captures of the chemiluminescence signals
from Western blots. In the case of the extractions with Triton
X-100, cholesterol depletion increases the 32 kDa band 30%,
with respect to control bands (Fig. 3A). Extractions with Lub-
rol WX yield increases in the 32 kDa in 70% respect to con-
trol bands (Fig. 3B). In addition, analyses of the released
p75NTR ectodomain present in the medium, by means of
immunoblot against an extracellular epitope (188–203), cor-
roborate the shedding enhancement by cholesterol removal
(Fig. 3C). These results point to the dispersion of choles-
terol-rich domains leading to the mixing of p75NTR with
TACE, initially segregated due to its localization in non-raft
domains, as the cause of the receptor proteolysis. Since phor-
bol ester 12-O-tetradecanoyl-phorbol-13 acetate (TPA) has
been described as an activator of p75NTR shedding [17], synap-
tosomes were alternatively treated with 200 nM for 15 min,conditions in which protein kinase C (PKC) has been described
as being activated in rat brain synaptosomes [30]. Treatment of
synaptosomes with TPA in PKC-activating conditions did not
cause signiﬁcant changes in the proteolytic activity in p75NTR,
to the contrary as has been described in other systems [19]. The
pro-proteolytic eﬀect of TPA on p75NTR has been described as
PKC-dependent, but also mediated by the MEK/ERK and p38
MAP kinase pathways [16]. Moreover, the participation of
reactive oxygen species in the TPA-mediated TACE action
has also been described [31], pointing to a complex mechanism,
which is probably incomplete in isolated nerve endings, thus
leading to an absence of TPA-induced proteolysis of p75NTR.
Alternatively, inhibition of c-secretase activity with the com-
pound N-[N-(3,5-diﬂuorophenacetyl)-L-alanyl]-(S)-phenylgly-
cine t-butyl ester (DAPT), did not cause the appearance of
any additional band in response to mbCD or to TPA (data
not shown).
3.3. TACE, but not presenilin-1, is excluded from lipid rafts
Analysis of TACE, described as critical for the ectodomain
shedding of p75NTR [16], in the gradient obtained with Tri-
ton X-100, demonstrates its complete absence in DRM
(Fig. 4A). The same result is obtained with Lubrol WX or with
Brij 98 (Fig. 4B and C). These results correlate with the
absence of p75NTR proteolysis in DRM (Figs. 1 and 2). Since
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Fig. 3. Cholesterol removal results in increased p75NTR shedding.
Synaptosomes were treated, where indicated, with 50 mM mbCD for
15 min or with 200 nM TPA for 15 min, previous to solubilization with
the indicated detergents (A, Triton X-100; B, Lubrol WX), and
subsequently fractionated in a discontinuous sucrose gradient. Frac-
tions 1–4 from each treatment were pooled and considered as the
DRM content, while Fractions 10–12 were pooled and considered as
the SM content. These pools were analyzed by Western blot using the
antibody that recognizes the intracellular (ICD) domain of p75NTR.
The signals due to the 32 kDa fragment were increased after
cholesterol removal, but not after TPA treatment. (C) Supernatants
of the experiments described in (A) were collected after elimination of
the synaptosomes by centrifugation. The same supernatant volumes
were immunoblotted using an antibody against the stalk domain
(residues 188–203). Treatment with mbCD yielded a soluble peptide of
45 kDa, corresponding to the released p75NTR ectodomain. These
analyses were repeated in three independent experiments with similar
results. Representative results are shown.
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Fig. 4. TACE, but not presenilin-1 fragments, is excluded from DRM.
Synaptosomes were solubilized in 1% Triton X-100 for 30 min at 4 C
(A), in 1% Lubrol WX for 30 min at 4 C (B) or in 1% Brij 98 for
30 min at 37 C. Subsequently, each treated sample was fractionated in
a discontinuous sucrose gradient, as detailed in Section 2. Equal
volumes of the recovered fractions were separated by SDS–PAGE and
transferred to nitrocellulose for immunoblotting analysis by using
antibodies against TACE (90–110 kDa), against the C-terminal
portion of presenilin-1 (PS1 CTF; 20 kDa) or against the N-terminal
portion of presenilin-1 (PS1 NTF; 30 kDa). The raft marker protein
Thy-1 is also shown in order to demonstrate the appropriate extraction
of DRM in both cases. This analysis was repeated in three independent
experiments with similar results. Representative results are shown.
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responsible for the ectodomain shedding of p75NTR [17], the
presence of PS1, the active core of the c-secretase complex,
was tested using antibodies against the C-terminal fragment
or against the N-terminal fragment of PS1 alternatively, and
also in the three detergent extractions (Fig. 4). The results
show a positive correlation between the distributions of both
fragments, C- and N-terminal, of PS1, in each detergent used.
On the one hand, Triton X-100 solubilizes PS1 fragments very
eﬀectively, with only 14% of these appearing in the DRM
(Fractions 1–4; Fig. 4A), as assessed by quantiﬁcation of the
Western blots as described in Section 2. On the other hand,
Lubrol WX extractions show the main content of PS1 frag-
ments in the DRM fractions (70%, Fig. 4B), thus showingan opposite and diﬀerent pattern from TACE, which appears
exclusively in soluble membranes. Finally, Brij 98 extracted
approximately 50% of both PS1 fragments in DRM, while
TACE was totally solubilized (Fig. 4C). The extraction of
membrane microdomains with this detergent is commonly car-
ried out at 37 C [32], thus avoiding the non-speciﬁc clustering
of lipidic components due to the low temperature conditions
used with other detergents, which could lead to the mistaken
assignment of proteins as raft residents. In order to corrobo-
rate the exclusion of TACE from lipid rafts, immunochemistry
analyses were conducted on synaptosomes. Confocal micro-
scope images show a total segregation between Thy-1, a raft
marker, and TACE (Fig. 5).4. Discussion
Since the segregation of membrane proteins from their
sheddases thanks to cholesterol-rich domains seems to be a
Fig. 5. Immunocytochemical detection of Thy-1 and TACE. Thy-1
immunoreactivity was detected with the use of a monoclonal antibody
and Alexa 488-labeled secondary antibody (signal shown in green),
whereas the presence of TACE was detected with the use of a
polyclonal antibody and revealed with the use of Alexa 546-labeled
secondary antibody (signal shown in red). Representative, unspeciﬁc
signal without primary antibodies is also shown. Confocal images
shown correspond to single z-sections taken at the same distance from
the substrate. Bar represents 4 lm.
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proteolysis or ectodomain shedding [15], we tested the distribu-
tion of the p75NTR sheddases, as well as the cholesterol-depen-
dence of the process. The main observation of the present
work is the absence of any proteolytic fragment of p75NTR
in lipid rafts, while a 32 kDa fragment appears in soluble mem-
brane fractions. Lipid rafts can act as positive regulators of
shedding processes, APP and PrP processing being relevant
cases [24,33,34], or as negative regulators of shedding pro-
cesses, as in the case of the interleukin-6 receptor [26] or of
CD30 [25]. Now, with the results described in the present
work, p75NTR can be included in the group of membrane pro-
teins whose shedding is prevented by lipid rafts. The a-secre-
tase activity acting on p75NTR, a pre-requisite for the
subsequent c-secretase cleavage, is likely to be due to TACE,
since stimulated p75NTR shedding is abrogated in M2 mutant
Chinese hamster ovary cells that lack functional TACE (also
referred to as ADAM17) and in cells isolated from
adam17/ mice, but not in cells from adam9/12/15/ or
adam10/ mice [16]. Additional data exist that support the
role of TACE in p75NTR processing. The combination of ﬁbro-
blast growth factor, NT-3 and BDNF induced the production
of TACE and c-secretase by retinal ganglion cells in vitro,
which led to the shedding of the Nogo receptor (NgR) and
of p75NTR, and the disinhibition of axon growth on inhibitory
CNS myelin substrates by attenuating inhibitory receptor sig-
naling, as determined by the reduced conversion of Rho-GDP
to Rho-GTP [35]. Our results ﬁnding a correlation between the
presence of TACE and proteolysis are consistent with the
attributed role of TACE in p75NTR shedding. Regarding the
action of PS1, its activity has been described in CHO cells as
cholesterol-dependent [36], leading to the possibility that the
enhancement of the 32 kDa shedding band in Fig. 3 could bedue to inhibition of PS1 activity by action of the cholesterol re-
moval. This possibility is not incompatible with the action of
TACE on p75NTR after raft dispersion due to mbCD, pointed
out in the present work. Then, the action of TACE and inhibi-
tion of PS1 could act in synergy in the appearance of the
32 kDa shedding band.
The sequence requirements for the initial a-secretase events
remain unknown, although mass spectrometric analysis con-
ﬁrmed that initial cleavage can occur in a truncated p75NTR
displaying only 15 extracellular aminoacids in the stalk region
[37]. On the other hand, the c-secretase cleavage site is well
established, acting on a Val–Val bond within an intramem-
brane sequence very similar to that of APP [17]. The c-secre-
tase-mediated p75NTR proteolysis plays a role in the
formation/disassembly of the p75-TrkA receptor complex by
regulating the availability of the p75 transmembrane domain
that is required for this interaction [17]. The results from the
present work, which show no proteolysis in the absence of
TACE (in spite of the presence of the active component of
the c-secretase complex, i.e., PS1) agree with the requirement
of a TACE action on the substrate prior to the c-secretase
cleavage, as described in HEK293 cells [37]. This mechanism
does not seem to be general, since the a-secretase-dependent
c-secretase activity is not observed in the case of neurotro-
phin-dependent release of p75NTR-ICD in Schwann cells,
which do not need the previous activation of a-secretase to
yield the release of p75NTR-ICD and to facilitate its transloca-
tion to the nucleus [38]. Besides neurotrophins, myelin-associ-
ated glycoprotein (MAG), which interacts with p75NTR
through the NgR [39], was also shown to activate receptor
cleavage by c-secretase, and this processing was essential for
the inhibition of neurite outgrowth [29]. Moreover, a recent re-
port demonstrates that p75NTR is cleaved by c-secretase in
sympathetic neurons, speciﬁcally in response to pro-apoptotic
ligands. This cleavage results in ubiquitination and subsequent
nuclear translocation of NRIF, a DNA-binding protein essen-
tial for p75NTR-mediated apoptosis. These results show that
p75NTR-mediated apoptosis requires c-secretase-dependent re-
lease of its ICD, which facilitates nuclear translocation of
NRIF [40].
The TACE-mediated cleavage of p75NTR generates a 55 kDa
extracellular domain (p75NTR-ECD) and a 32 kDa cytoplas-
mic transitional fragment (p75NTR-CTF), and, from the latter,
a 25 kDa intracellular domain (p75NTR-ICD) is generated after
c-secretase action [17,41]. Although the levels of p75NTR-ICD
produced are tightly controlled by rapid removal via proteos-
omal degradation, p75NTR-ICD can travel to the nucleus and
activate apoptosis via transcription factor NF-kB [19]. In our
experiments a 32 kDa fragment of p75NTR was found (compat-
ible with the molecular weight of the p75NTR-CTF), but we
were unable to detect p75NTR-ICD, even after proteosomal
inhibition using compound MG-132 (data not shown).
The aﬃnity of p75NTR for lipid rafts is well established [42–
45], but the events that control this distribution and its signif-
icance are just beginning to be understood. Now, thanks to the
results shown in this work, the modulation of the p75NTR ecto-
domain shedding can be considered as a new role exerted by
lipid rafts, shedding light on the signiﬁcance of association
of p75NTR with lipid microdomains. In previous works, associ-
ation of p75NTR with sphingomyelinase was demonstrated to
exist in caveolae (a sub-set of lipid rafts) [42], and it has been
shown to correlate with cell diﬀerentiation and survival in
C. Gil et al. / FEBS Letters 581 (2007) 1851–1858 1857p75NTR-transfected NIH 3T3 cells and in PC12 cells through
the production of ceramide from sphingomyelin [46], hence
pointing to the role of raft-associated p75NTR as a component
in the control of cell viability. Supporting the role of the raft-
associated p75NTR in neuronal enhancement, modulation by
the brain-speciﬁc isoform (Cb) of cAMP-dependent protein ki-
nase (PKA) of p75NTR-mediated neurite outgrowth has been
demonstrated, presumably by phosphorylating p75NTR and
inducing its translocation into lipid rafts [47]. Interestingly,
Rac1, a p75NTR-binding protein, also translocates to lipid rafts
after neurotrophin treatment, mediating neurite outgrowth
activity [48]. Another factor that induces the association of
p75NTR with lipid rafts and the activation of associated signal
transduction is the binding of soluble myelin-associated glyco-
protein (MAG) to speciﬁc gangliosides, showing that lipid
rafts are necessary components for the inhibitory eﬀects of
MAG-Fc and the Nogo peptide through p75NTR [49]. This
inhibitory eﬀect of raft-resident p75NTR from neurons is per-
formed by interaction with raft-resident binding partners from
adjacent glia, having functional signiﬁcance in the inhibition of
central nervous system regeneration following injury and in the
maintenance of myelin integrity [45].
In summary, our results provide evidence that the segrega-
tion between p75NTR and TACE, by means of their diﬀerential
localization into lipid rafts, could protect the neurotrophin
receptor from a-secretase proteolysis, which would permit a
higher degree of interaction of the receptor with its ligands
or prevent nuclear signaling due to the subsequent formation
of p75NTR-ICD.
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